“We go into the hospital to see the patient, in the dialysis ward and bring them a little something to brighten up their day.”
In this episode, I talked with Chris Lowe, CEO of Nusano, where he discusses his career journey in the medical technology field, particularly focusing on the production of medical radioisotopes. He shares insights on leadership, the importance of building a talented team, and the societal responsibilities of his company. Chris also highlights common mistakes in drug development and reflects on a case study from his past. Our conversation emphasizes the significance of patient-centric approaches in the industry.
Here's what you're in:
- The highest and lowest career points of Chris’ career.
- Why medical radioisotopes production is so important and how Nusano is approaching this.
- What role does leadership play in hiring talented individuals and giving them the freedom to succeed?
- How should recruitment focus on finding the right fit for both the candidate and the company?
- Exploring mistakes that companies are still making today.
- How does the Francis trial serve as a case study in navigating regulatory challenges?
- What role does recognizing the societal impact of work play in building a strong company culture?
- How does prioritizing patient well-being ultimately benefit a business?
Timestamps:
04:51 Proudest Moment of Chris in his Career and Leadership Philosophy
07:41 Nusano: Innovations in Medical Radioisotope Production
13:55 Building a Talented Team at Nusano
17:57 Company Culture and Societal Responsibility
19:48 Common Mistakes Companies Are Still Making Today
22:40 Case Study: The Francis Trial
30:24 Final Thoughts on Patient-Centric Drug Development
Episode Links:
- Spotify: https://open.spotify.com/episode/42xzR8jETl93YGITQuYiYs?si=9466405ef5ce4aec
- Apple Podcast: https://podcasts.apple.com/us/podcast/chris-lowe-ceo-at-nusano-radioisotopes-volunteering/id1736051162?i=1000702549902
About Chris
- Chris Lowe is the CEO of Nusano, a privately-held medical technology company that specializes in the production of medical radioisotopes used for diagnosing and treating diseases such as cancer.
- Chris has led 5 IPOs as a C-level executive, all focused on supporting therapeutic development, while efficiently building and scaling operations.
- Prior to this, he spent 3 years with Cortexyme as COO and CFO.
- He has over 15 years of C-Suite experience in various private and public life sciences, medical technology, and technology companies.
Connect with Chris
LinkedIn: https://www.linkedin.com/in/chrislowe7/
About Nusano
- Nusano is a physics-based medical technology company specializing in the production of radioisotopes.
- It focuses on therapeutic applications, particularly in oncology, with potential expansion into other medical areas.
- Developed a unique ion source capable of generating high levels of alpha particles and deuterons.
Company Website: https://nusano.com/
About me
My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.
In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.
Connect with me:
LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/
Website: https://www.discera-search.com/
